Effect of sex class on the levels of some biochemical variables in thalassemia patients
Article Sidebar
Main Article Content
Abstract
The study was conducted at Azadi Teaching Hospital - Thalassemia Center for the period from 1/10/2017 to 1/4/2018. It included 60 patients including 30 males and 30 females, as well as control group which included 20 Healthy people were all 10 to 21 years of age. The following variables were studied: ferritin, GSH, insulin-like growth factor-1 (IGF-1) Malondialdehyde (MDA) Interleukin-6 (IL-6), and Cortisol. The analysis of correlation coefficients and simple linear regression was carried out to determine the effect of the variables among them. The results were as follows: Thalassemia patients recorded the lowest levels of GSH, IGF-1 and cortisol at 2.2 μmol / L and 50.4 ng / ml and 10.11 μg / dL respectively, while the same group recorded the highest levels of ferritin, MDA and IL- 6 was 3083 ng / ml, 941 mmol / L and 368 pg / mol. There were significant effects of both sexes in the group of thalassemia patients in both ferritin, GSH, IGF-1, MDA, and IL-6 with 2573, 3592 μg / dL, 2.821, 1.573 μmol / L, 63.3, 37.47 ng / ml and 1163.1 719.3 mmol / L 300.9 and 435.6 pg / mol for males and females, respectively. The results of the correlation coefficient analysis showed existence of and low correlations in the negative and positive direction between the study variables of the two groups of patients and control. The results of the simple linear regression analysis showed positive and negative regression ratios of IL-6 and IGF-1 growth factor on the rest of the study variables.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Vichinsky, EP,, MacKIin EA, Waye JS, Lorey F(2005), OIivieri NF Changes in the epidemio logy of Thalassemia in North America a new minority disease. Pediatnics 116(6) :e818.
[2] Cooley, TB. (1946), M.D. 1871-1945. Am J Dis Child, 71, p.p. 77-79.
[3] Swanson, T.W., Meneghetti, A.T., Sampath, S., Connors, J.M and Panton, O.N(2011). Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre. Canadian J. of Surgery.; 54: 189-193.
[4] Nielsen FF, Mikkelsen BB, Nielsen JB, Andersen HR and Grandgean P (1997),. Plasma malondialdehyde as biomarker for oxidative stress:
reference interval and effects of life- style factors. Clinical Chemistry.; 43: 1209-1214.
[5] Ren J, Anversa P(2015). The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem Pharmacol.; 93:409–417.
[6] Brahmkhatri, V. P.., Prasanna, C., & Atreya, H. S (2015).. Insulin-like growth factor system in cancer: novel targeted therapies. BioMed Research International.
[7] Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M (2013)IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond 122: 143–159.
[8] Kang S, Tanaka T, Kishimoto T.(2015) Therapeutic uses of anti-interleukin-6 receptor antibody. Int Immuno l27:21–29.
[9] Erichsen MM, Lovas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab94:4882-4890.
[10] Porter, J.B. , (2005)Monitoring and treatment of iron overload: state of the art and new approaches. Semin Hematol. 42: s14-8.
[11] Koca SS, Isik A, Ustundag B, Metin K, Aksoy K (2010) Serum prohepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation 31: 146-153.
[12] Khalil, S.; Amer, H.; El Behairy, A. and Warda, M. (2016). Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies; Journal of Advanced Research .7. 348–358.
[13] Al-Hakeim, Hussein Kadhem Abdul Hussein and Manal Farhan Mohsen Al-Hakany(2013). The Effect of Iron Overload on the Function of Some Endocrine Glands in β-Thalassemia Major Patients. Magazin of Al-Kufa University for Biology, Vol 5, No 2.
[14] Nasr, M.R.; N.A. Ebrahim; M.S. Ramadan and O. (2014)Salahedin Growth pattern in children with beta-thalassemia major and its relation with serum ferritin, IGF1 and IGFBP3. JCEI. 3 (2): 157-163.172- Ussein, K.A, N.R. Othman and K.J. Qadir Study of Physical Growth Pattern in Thalassemic Children and Adolescent in Hawler Thlassemia Center /Erbil City. Kufa J. for Nursing Sci.,. 4(2): 160-166.
[15] Majeed, M.S. (2017) Evaluation of some Biochemical and Endocrine Profiles in transfusion-dependent Iraqi major β - thalassemia patients. Iraqi Journal of Science, Vol. 58, No.2A,. pp: 639-645.
[16] Kassim, B.S.J. (2016) Study of thyroid gland function before and after splenectomy in Beta-thalassaemia major male patients in Kirkuk city. Thesis of Master. Department of Physiology, College of Medicine, University of Tikrit..
[17] Kalpravidh, R.W.; Th. Tangjaidee, S. Hatairaktham, R. Charoensakdi, N. Panichkul, N. Siritanaratkul and S. (2013)Fucharoen. Glutathione Redox System in